INTERCEPT PHARMACEUTICALS IN shareholder history

Current and past INTERCEPT PHARMACEUTICALS IN shareholders
Period Weighting Quarter
CompanyLongestShortestMin.Avg.Max.FirstLatest↓ Count
JPMORGAN CHASE & CO 550.00%0.00%0.00%Q3 2022Q3 20235
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 551.61%2.03%2.32%Q3 2022Q3 20235
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 550.00%0.00%0.00%Q3 2022Q3 20235
CITIGROUP INC 550.00%0.00%0.00%Q3 2022Q3 20235
JANE STREET GROUP, LLC 440.00%0.00%0.00%Q4 2022Q3 20234
WOLVERINE ASSET MANAGEMENT LLC 330.09%0.09%0.10%Q1 2023Q3 20233
Graham Capital Management, L.P. 330.12%0.15%0.18%Q4 2022Q2 20233
COWEN AND COMPANY, LLC 220.10%0.10%0.10%Q3 2022Q4 20222
Bank of New York Mellon Corp 220.00%0.00%0.00%Q3 2022Q4 20222
LAZARD ASSET MANAGEMENT LLC 220.01%0.01%0.01%Q3 2022Q4 20222
AMERICAN CENTURY COMPANIES INC 220.00%0.00%0.00%Q3 2022Q4 20222
Man Group plc 220.00%0.00%0.00%Q3 2022Q4 20222
CSS LLC/IL 110.32%0.32%0.32%Q3 2023Q3 20231
ROYAL BANK OF CANADA 110.01%0.01%0.01%Q3 2022Q3 20221
Context Capital Management, LLC 110.00%0.00%0.00%Q3 2022Q3 20221

This page lists all the filers that currently own INTERCEPT PHARMACEUTICALS IN or have owned INTERCEPT PHARMACEUTICALS IN in the past.